Hospital
Tyler Holmes Memorial Hospital
Tyler Holmes Memorial Hospital was paid $6.39M by Medicaid between Jan 2018 and Dec 2024, across 90 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.
33Billing provider infoTYLER HOLMES MEMORIAL HOSPITAL
WINONA, MS 38967
WINONA, MS 38967
33aNPI1205868627assigned 07/07/2006
33bProvider typeCritical Access Hospital
28Total paid$6.39M
24GClaims164,827
24DCodes billed90
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Mississippi
Rank by total paid#11 of 32
Median peer was paid$3.94M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,006 | $731K | |
| 2019 | 14,835 | $736K | |
| 2020 | 16,289 | $702K | |
| 2021 | 20,333 | $812K | |
| 2022 | 30,727 | $1.16M | |
| 2023 | 35,483 | $1.22M | |
| 2024incomplete | 30,154 | $1.03M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 9,176 | 7,757 | $1.21M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 6,767 | 5,607 | $1.13M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 3,999 | 3,172 | $685K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8.7% | 11,662 | 2,161 | $556K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.6% | 8,102 | 6,892 | $292K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.5% | 5,388 | 4,204 | $225K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.9% | 2,090 | 1,710 | $188K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 2,223 | 1,734 | $178K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.4% | 8,580 | 4,768 | $150K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.2% | 2,344 | 2,025 | $143K |
| 71045 | Radiologic examination, chest; single view | 2.0% | 3,379 | 2,626 | $125K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 1,532 | 1,301 | $118K |
78 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.8% | 1,390 | $117K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 3,690 | $86K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.3% | 938 | $85K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 1,920 | $83K |
| 80053 | Comprehensive metabolic panel | 1.3% | 9,234 | $83K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.3% | 1,615 | $80K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 12,053 | $79K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.2% | 944 | $76K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 1,449 | $72K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,561 | $61K |
| 87430 | <1% | 4,656 | $57K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,327 | $46K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,303 | $43K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,178 | $34K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 136 | $30K |
| 83880 | <1% | 1,653 | $28K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,346 | $26K |
| 97016 | <1% | 2,461 | $23K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,763 | $22K |
| 84484 | <1% | 3,109 | $21K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 900 | $20K |
| G0378 | Hospital observation service, per hour | <1% | 111 | $20K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 122 | $16K |
| 80061 | Lipid panel | <1% | 1,397 | $16K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,006 | $13K |
| 82553 | <1% | 1,570 | $11K | |
| 81001 | <1% | 4,676 | $11K | |
| 97161 | <1% | 228 | $10K | |
| 86756 | <1% | 568 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,267 | $10K |
| 82550 | <1% | 1,774 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,181 | $7K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 171 | $7K |
| 81025 | <1% | 1,000 | $7K | |
| 80306 | <1% | 707 | $7K | |
| 71250 | <1% | 85 | $6K | |
| 83735 | <1% | 1,798 | $6K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,571 | $3K |
| 83690 | <1% | 753 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 57 | $3K |
| 87428 | <1% | 57 | $3K | |
| 87040 | <1% | 438 | $3K | |
| 73560 | <1% | 76 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 70 | $3K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 140 | $3K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 37 | $3K |
| 83605 | <1% | 668 | $3K | |
| 85378 | <1% | 503 | $2K | |
| A9270 | Non-covered item or service | <1% | 2,492 | $2K |
| 82077 | <1% | 140 | $2K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 1,690 | $2K |
| 82803 | <1% | 154 | $1K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 50 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,474 | $1K |
| 81002 | <1% | 291 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 47 | $916.38 |
| 74018 | <1% | 14 | $626.00 | |
| 87449 | <1% | 50 | $575.54 | |
| 85610 | <1% | 227 | $552.82 | |
| 51702 | <1% | 17 | $459.30 | |
| 82150 | <1% | 69 | $453.28 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 499 | $308.40 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 255 | $277.12 |
| 87625 | <1% | 186 | $271.00 | |
| 85730 | <1% | 71 | $227.12 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 23 | $224.38 |
| 80177 | <1% | 22 | $190.88 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 679 | $169.28 |
| 86140 | <1% | 61 | $119.18 | |
| 84520 | <1% | 73 | $94.15 | |
| 85027 | <1% | 84 | $74.53 | |
| 81003 | <1% | 29 | $36.54 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 12 | $20.30 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 31 | $13.20 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 15 | $8.80 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 40 | $6.86 |
| 84145 | 0% | 49 | $0.00 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 84 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBAILEY, CORI (ADMINISTRATOR)